Aurobindo's subsidiary Tergene Biotech receives SEC recommendation for pneumococcal 15 valent vaccine

The company continue to develop this program for the WHO markets, thereby providing coverage and protection for more infants globally in time to come

WBF signs MOU with Sharda University to help advance biocontrol sector

De Nora and Aclarity sign agreement to deploy PFAS destroying technology

The MOU will involve product collaboration from both companies with a goal of propelling PFAS destruction in groundwater globally

BASF and MedAccess complete shipment of 35 million interceptor G2 nets to fight malaria

35 million mosquito nets supplied to countries in sub-Saharan Africa through partners

Valneva and Pfizer report antibody persistence data for lyme disease vaccine candidate

Antibody levels remained above baseline six months after completion of a three-dose (Month 0-2-6) or a two-dose (Month 0-6) vaccination schedule

World’s first intra-nasal vaccine for COVID developed by India has got approval from CDSCO

Phase-III trials were conducted for safety, and immunogenicity in around 3,100 subjects, in 14 trial sites across India (supported by BIRAC)

Briefs: Piramal Enterprises and Shilpa Medicare

Shilpa Medicare Ltd's finished dosage form manufacturing facility, Unit IV, situated at Pharma SEZ, Jadcherla, Telangana has received Health Canada GMP approval

CPHI & PMEC India 2022 showcases array of machinery, ingredients and technology

South Asia’s largest exhibition for pharma brought together over 50,000 visitors from across the globe

USFDA grants priority review of BLA for dengue vaccine TAK-003

If approved, TAK-003 has the potential to become an important dengue prevention option for healthcare providers

Pfizer and BioNTech report new data on Omicron BA.4/BA.5-adapted bivalent booster

Omicron BA.5 continues to be the most prevalent sublineage in the United States (nearly 30% of cases) at the time of publication of the data